First OTC drug approved for women with overactive bladder

(HealthDay)—The drug Oxytrol has been approved by the U.S. Food and Drug Administration as the first over-the-counter treatment for women 18 and older with overactive bladder.

is characterized by symptoms including leakage, frequent urination and feeling the sudden and urgent need to urinate. The condition affects some 33 million Americans, mostly older women.

Oxytrol contains oxybutynin, among a class of drugs called anticholinergics that are designed to relax the . Oxytrol is a patch applied to the skin every four days, the FDA said in a news release.

The drug will remain available for adult men by prescription only, the agency said.

Side effects reported during clinical testing included skin irritation at the patch site, dry mouth and constipation.

Oxytrol for Women is marketed by Merck, based in Whitehouse Station, N.J.


Explore further

Myrbetriq approved for overactive bladder

More information: To learn more about overactive bladder, visit the U.S. Department of Health and Human Services.

Health News Copyright © 2013 HealthDay. All rights reserved.

Citation: First OTC drug approved for women with overactive bladder (2013, January 25) retrieved 29 January 2020 from https://medicalxpress.com/news/2013-01-otc-drug-women-overactive-bladder.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments